Quarterly Report • Apr 20, 2023
Quarterly Report
Open in ViewerOpens in native device viewer
Talenom's growth continued as strong in line with the selected strategy
1 Jan to 31 March 2023 (unaudited)

Talenom's growth continued as strong in line with the selected strategy
| Group | 1–3/2023 | 1–3/2022 | Change, % |
|---|---|---|---|
| Net sales, EUR 1,000 | 31,311 | 25,209 | 24.2% |
| Net sales, increase % | 24.2% | 24.1% | |
| EBITDA, EUR 1,000 | 8,365 | 8,864 | -5.6% |
| EBITDA of net sales, % | 26.7% | 35.2% | |
| Operating profit (EBIT), EUR 1,000 | 3,458 | 4,861 | -28.9% |
| Operating profit (EBIT), as % of net sales | 11.0% | 19.3% | |
| Return on investment (ROI), % (rolling 12 months) | 11.7% | 16.8% | |
| Interest-bearing net liabilities, EUR 1,000 | 68,060 | 46,573 | 46.1% |
| Net gearing ratio, % | 130% | 106% | |
| Equity ratio, % | 31.4% | 34.6% | |
| Net investments, EUR 1,000 | 12,641 | 7,402 | 70.8% |
| Liquid assets, EUR 1,000 | 13,255 | 12,891 | 2.8% |
| Earnings per share, EUR | 0.05 | 0.09 | -46.7% |
| Weighted average number of shares during the period | 44,893,388 | 43,731,739 | 2.7% |
| Net profit, EUR 1,000 | 2,057 | 3,748 | -45.1% |
Talenom estimates that 2023 net sales will be about EUR 120–130 million and that its euro-denominated EBITDA and operating profit will grow from 2022.
Talenom wants to promote the digitalization of Europe's SMEs. We believe, the time for strong growth is now, because the European financial management market is becoming digitalized and consolidated. This change is accelerated by several ongoing significant structural changes in the industry. For example, the introduction of the e-invoicing directive in the EU will force every company to implement software that enables sending and receiving e-invoices. We have systematically developed our systems to respond to the changes in the operating environment brought on by digitalization. We have, thus, chosen strong growth as a strategic focus area in many different European countries, although it will burden our shortterm relative profitability.
During the first quarter, we made determined progress on strategic priorities:
In the first quarter, our net sales increased by 24.2% (24.1) to EUR 31.3 million (25.2), which was slightly below the targeted level due to volume-based and consultative invoicing and the exchange rate effect of the weak SEK. The growth was based on several acquisitions in Sweden and Spain and strong organic growth in Finland. EBITDA was EUR 8.4 million (8.9) and the EBITDA margin was still strong at 26.7% (35.2). EBITDA was depressed by the system platform acquired in Spain in autumn 2022 that had a weakening effect of around EUR 0.5 million (0.0) on EBITDA. In addition, the weakening effect of nonrecurring items related to acquisitions and other expenses was EUR 0.5 million compared to the comparison period. Operating profit was EUR 3.5 million (4.9) and the EBIT margin was 11.0% (19.3). Relative profitability was depressed by our planned investments in growth, wage inflation, as well as integration and other costs arising from acquisitions.
In Finland, net sales grew by 11.5% (16.5) to EUR 23.4 million (21.0). EBITDA was EUR 8.3 million (8.3). The EBITDA margin was excellent at 35.4% (39.5). Increased costs were not passed on to customer prices until the end of the reporting period, which was reflected in weakened relative profitability. The very strong performance of the Finnish business continued. The working time freed up by the high degree of automation enabled delivery of more extensive monthly service packages. Thanks to more extensive services we managed to win over more new customers than targeted.
In Sweden, growth continued as strong driven by acquisitions. Net sales grew by 68.6% (73.1) to EUR 6.7 million (4.0). EBITDA was EUR 0.8 million (0.5) representing 11.9% (11.6) of net sales. The weak Swedish krona had a negative impact on euro-denominated net sales and EBITDA development. Sweden's profitability is still burdened by strengthening the organization as planned and accelerating integration, as well as implementation of the own software. These costs are front-loaded.
In Spain, acquisition-driven growth accelerated. We have utilized our experience of becoming established in Sweden and strengthened resources in management on a front-loaded basis while simplifying and accelerating integration processes. In Spain, we also harmonized our product offering to boost growth and launched robotics projects to improve process efficiency. Measured by EBITDA, the Spanish accounting business is profitable. The profitability of the Spanish business is burdened by the platform business. The platform enables customer segmentation, which supports future profitability growth. In Italy, we continue to learn about the market and operating environment through the acquisition we completed.
The profitability of the first quarter was mainly depressed by non-recurring costs related to acquisitions and the Spanish platform business. In Spain, we are moving to a more profitable customer segment in the platform business and implementing changes in processes that improve profitability. We also expect the profitability of Finland's business to improve thanks to price increases.
We keep our guidance unchanged. We estimate that our 2023 net sales will be about EUR 120–130 million and that euro-denominated EBITDA and operating profit will grow from 2022.


Net sales development, EUR million

EBIT development, EUR million

Net sales increased by 24.2% to EUR 31.3 million (25.2). Some 60% of the increase in net sales came from acquisitions and some 40% organically through growth in customer numbers and sales of value-added services in Finland.
Personnel costs amounted to EUR 18.1 million (13.4) representing 57.8% (53.2) of net sales. Other operating expenses, including materials and services, totalled EUR 5.1 million (3.4) or 16.1% (13.5) of net sales.
EBITDA decreased by -5.6% to EUR 8.4 million (8.9) or 26.7% (35.2) of net sales. EBITDA was depressed by the system platform acquired in Spain in autumn 2022 that had a weakening effect of around EUR 0.5 million (0.0) on EBITDA. In addition, the weakening effect of non-recurring items related to acquisitions and other expenses was EUR 0.5 million compared to the comparison period. Operating profit decreased by -28.9% to EUR 3.5 million (4.9) or 11.0% (19.3) of net sales. Relative profitability was depressed by our planned investments in growth, wage inflation, as well as integration and other costs arising from acquisitions. Net profit decreased by -45.1% to EUR 2.1 million (3.7). Net financial expenses increased to EUR 0.7 million (0.1).
| 1–3/2023 | 1–3/2022 | Change, % | |
|---|---|---|---|
| Net sales, EUR 1,000 | 23,377 | 20,965 | 11.5% |
| Net sales growth, % | 11.5% | 16.5% | |
| EBITDA, EUR 1000 | 8,278 | 8,274 | 0.0% |
| EBITDA of net sales, % | 35.4% | 39.5% | |
| Depreciation and amortisations, EUR 1,000 | -4,155 | -3,612 | 15.0% |
| Operating profit, EUR 1,000 | 4,123 | 4,661 | -11.6% |
| Operating profit of net sales, % | 17.6% | 22.2% |
Net sales increased by 11.5% to EUR 23.4 million (21.0). Growth was mainly organic and was driven by increased customer numbers and sales of value-added services. Bankruptcies and business closures increased, but their impact on Talenom's business was limited.
Measured by EBITDA and operating profit, relative profitability weakened. Nevertheless, profitability was still at an excellent level. Increased costs were not passed on to customer prices until the end of the reporting period, which was reflected in weakened relative profitability.
| 1–3/2023 | 1–3/2022 | Change, % | |
|---|---|---|---|
| Net sales, EUR 1,000 | 6,727 | 3,989 | 68.6% |
| Net sales growth, % | 68.6% | 73.1% | |
| EBITDA, EUR 1000 | 800 | 461 | 73.5% |
| EBITDA of net sales, % | 11.9% | 11.6% | |
| Depreciation and amortisations, EUR 1,000 | -585 | -378 | 55.0% |
| Operating profit, EUR 1,000 | 214 | 84 | 156.5% |
| Operating profit of net sales, % | 3.2% | 2.1% |
Net sales increased by 68.6% to EUR 6.7 million (4.0). Net sales growth came mainly from acquisitions. The weak Swedish krona had a negative impact on euro-denominated net sales development.
Relative EBITDA was 11.9% (11.6) and operating profit 3.2% (2.1) of net sales. Sweden's profitability is still burdened by strengthening the organization as planned and accelerating integration, as well as implementation of the own software. The weak Swedish krona had a negative impact on eurodenominated EBITDA development.
| 1–3/2023 | 1–3/2022 | Change, % | |
|---|---|---|---|
| Net sales, EUR 1,000 | 1,207 | 256 | 372.3% |
| Net sales growth, % | 372.3% | ||
| EBITDA, EUR 1000 | -435 | -62 | -607.0% |
| EBITDA of net sales, % | -36.0% | -24.1% | |
| Depreciation and amortisations, EUR 1,000 | -168 | -12.3 | 1261.8% |
| Operating profit, EUR 1,000 | -602 | -73.8 | -716.1% |
| Operating profit of net sales, % | -49.9% | -28.9% |
Net sales increased by 372.3% to EUR 1.2 million (0.3). Net sales growth came mainly from acquisitions.
Business was loss-making. Measured by EBITDA, the Spanish accounting business is profitable. The profitability of the Spanish business is burdened by the platform business. The platform enables customer segmentation, which supports future profitability growth.
Unallocated items include revenue and cost recognition of additional purchase prices related to acquisitions.
| 1–3/2023 | 1–3/2022 | Change, % | |
|---|---|---|---|
| Net sales, EUR 1,000 | |||
| Net sales growth, % | |||
| EBITDA, EUR 1000 | -278 | 190 | |
| EBITDA of net sales, % | |||
| Depreciation and amortisations, EUR 1,000 | |||
| Operating profit, EUR 1,000 | -278 | 190 | |
| Operating profit of net sales, % |
The total net investments during the review period were EUR 12.6 million (7.4).
| Investments | Q1 2023 | Q1 2022 |
|---|---|---|
| New customer agreements, EUR 1,000 | 778 | 886 |
| Software and digital services, EUR 1,000 | 3,769 | 3,172 |
| Acquisitions in Finland, EUR 1,000 | 0 | 282 |
| Acquisitions abroad, EUR 1,000 | 7,198 | 2,897 |
| Other investments | 896 | 166 |
| Total net investments, EUR 1,000 | 12,641 | 7,402 |
*) includes an estimated EUR 0 (46,000) in recorded additional deal prices
**) includes an estimated EUR 1,570,000 (872,000) in recorded additional deal prices
Business acquisitions in January-March:
Share transactions in January-March:
Purchase prices, net sales and operating profit of the acquisition targets during the review period:
| EUR 1,000 | Share transactions | Business acquisitions |
|---|---|---|
| Total purchase prices | 5,587 | 270 |
| Maximum contingent consideration | 1,982 | 170 |
| Net sales, previous 12 months at time of purchase, total | 4,306 | 553 |
| Operating profit, previous 12 months at time of purchase, total | 1,071 | 0 |
In acquisitions, part of the purchase price was paid with new Talenom Plc shares subscribed for in directed issues. A total of 212,456 shares were subscribed for in directed share issues related to acquisitions during the review period.
This Business Review is not an Interim Financial Report prepared in accordance with the IAS 34 standard. The Company prepares its interim financial reporting in accordance with the Securities Market Act, in addition to which the Company releases Business Reviews for the first three and first nine months of the year. The Business Reviews contain key information regarding the financial position and development of the Talenom Group.
The figures of the Business Review are unaudited.
The Company reports commonly applied alternative performance measures to reflect the underlying business performance and enhance comparability between financial periods. Alternative performance measures i.e. performance measures not based on IFRS standards provide notable supplemental information to management, investors and other interested parties. Alternative performance measures may not be considered as a substitute for measures of performance in accordance with IFRS. Alternative performance measures used by the company include operating profit (EBIT), operating profit (EBIT) as % of net sales, EBITDA, EBITDA as % of net sales, return on investment (ROI) %, interest-bearing net liabilities, net gearing ratio %, equity ratio %, working capital and net investments. The formulas and explanations of alternative performance measures are presented below under section Formulas.
| EUR 1,000 | 1–3/2023 | 1–3/2022 | 2022 |
|---|---|---|---|
| Net sales | 31,311 | 25,209 | 102,107 |
| Other operating income | 197 | 486 | 1,625 |
| Materials and services | -933 | -853 | -3,950 |
| Employee benefit expenses | -18,088 | -13,421 | -55,682 |
| Depreciation and amortisations | -4,908 | -4,002 | -17,128 |
| Other operating expenses | -4,122 | -2,559 | -11,706 |
| Operating profit | 3,458 | 4,861 | 15,266 |
| Financial income | 111 | 174 | 466 |
| Financial expenses | -819 | -315 | -1,178 |
| Net financial expenses | -708 | -140 | -712 |
| Profit (loss) before taxes | 2,750 | 4,721 | 14,554 |
| Income taxes | -692 | -973 | -2 753 |
| Profit (loss) for the financial period | 2,057 | 3,748 | 11,801 |
| Other items of comprehensive income | |||
| Items that may be reclassified subsequently to profit or loss | |||
| Translation differences | 99 | 8 | 57 |
| Total comprehensive income for the financial period | 2,157 | 3,756 | 11,858 |
| EUR 1,000 | 31 March 2023 | 31 March 2022 | 31 Dec. 2022 | |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets | ||||
| Goodwill | 59,778 | 39,914 | 54 986 | |
| Other intangible assets | 49,264 | 37,860 | 45 806 | |
| Right-of-use assets | 10,709 | 8,766 | 9 922 | |
| Property, plant and equipment | 3,359 | 2,724 | 2 752 | |
| Other non-current financial assets | 259 | 850 | 254 | |
| Deferred tax assets | 472 | 115 | 443 | |
| Capitalised contract costs | 11,572 | 11,889 | 11 694 | |
| Total non-current assets | 135,413 | 102,117 | 125 857 | |
| Current assets | ||||
| Trade and other receivables | 17,543 | 12,127 | 14 178 | |
| Current tax assets | 545 | 101 | 315 | |
| Cash and cash equivalents | 13,255 | 12,891 | 15 970 | |
| Total current assets | 31,343 | 25,119 | 30 463 | |
| Total assets | 166,756 | 127,236 | 156,320 | |
| CAPITAL AND RESERVES | ||||
| Share,capital | 80 | 80 | 80 | |
| Reserve,for,invested,unrestricted,equity | 28,909 | 23,893 | 26 861 | |
| Retained,earnings | 23,300 | 19,911 | 29 085 | |
| Total equity | 52,289 | 43,884 | 56,026 | |
| LIABILITIES | ||||
| Non-current,liabilities | ||||
| Financial,liabilities | 60,258 | 50,149 | 50 122 | |
| Trade,and,other,payables | 3,530 | 2,959 | 2 845 | |
| Lease,liabilities | 6,798 | 5,940 | 6 256 | |
| Deferred,tax,liabilities | 3,601 | 2,050 | 3 040 | |
| Total,non-current,liabilities | 74,187 | 61,098 | 62 263 | |
| Current,liabilities | ||||
| Financial,liabilities | 10,000 | 16 | 10 001 | |
| Trade,and,other,payables | 26,315 | 18,862 | 23 724 | |
| Lease,liabilities | 3,919 | 3,037 | 3 705 | |
| Current,tax,liabilities | 46 | 340 | 601 | |
| Total,current,liabilities | 40,280 | 22,255 | 38 032 | |
| Total liabilities | 114,467 | 83,352 | 100,295 | |
| Total equity and liabilities | 166,756 | 127,236 | 156,320 |
| = | net sales - net sales of the preceding year | ||
|---|---|---|---|
| Net sales, increase % | net sales of the preceding year | x 100 | |
| Operating profit | = | net sales + other operating income - materials and services - personnel expenses - depreciations and amortisations - other operating expenses |
|
| Operating profit (EBIT), % | = | operating profit (EBIT) net sales |
x 100 |
| Return on investment (ROI), % (rolling 12 months) |
= | operating profit (EBIT) before taxes + interest and other financial expenses total equity and liabilities - non-interest-bearing liabilities (average of the accounting period) |
x 100 |
| Interest-bearing net liabilities |
= | interest-bearing liabilities - cash in hand and in banks | |
| Net gearing ratio, % | = | interest-bearing liabilities - cash in hand and in banks capital and reserves |
x 100 |
| Equity ratio, % | = | capital and reserves balance sheet total - advances received |
x 100 |
| Working capital | = | inventories + non-interest-bearing current receivables - non interestbearing current liabilities |
|
| Net investments | = | investments in tangible and intangible assets - sales of assets | |
| Earnings per share | = | net profit of the review period Weighted average number of shares outstanding during the review x 100 period |
x 100 |
| Compound annual growth rate (CAGR) |
= | 1 net sales at the end of the period ( net sales in the beginning of the period ) number of years -1 |
|
| EBITDA | = | operating profit + depreciation + amortisation | |
| EBITDA, % | = | EBITDA Net sales |
x 100 |
Operating profit (EBIT) measures Talenom's ability to generate a profit in its business operations. Operating profit is a key metric of the company's profitability and financial performance, and indicates the profit generated from business operations.
Operating profit margin refers to operating profit as a percentage of net sales and is used to proportion operating profit in relation to net sales and improve comparability of operating profit over reporting periods.
Return on investment, meanwhile, measures operating result in relation to invested equity. It describes Talenom's relative profitability, in other words how effectively the company is able to generate profit for capital invested in the company
Interest-bearing net liabilities is the net sum of Talenom's debt financing. The metric provides information on the company's indebtedness and capital structure.
Net gearing ratio is the ratio between Talenom's equity and interest-bearing liabilities. It describes the level of risk associated with the company's financing and is a useful metric for tracking the company's debt to equity ratio.
Equity ratio is a financial structure metric that shows what proportion of the company's balance sheet is financed by its own equity. Equity ratio provides information on the level of risk associated with financing and the level of equity used in business operations, and describes the company's solvency and tolerance against loss in the long term.
Working capital measures the amount of financing committed in Talenom's business operations and describes the efficiency of capital use.
Net investments measure the amount of investments minus the sale of fixed assets. The metric offers additional information on the cash flow needs of business operations.
EBITDA is an important key figure that measures Talenom's ability to generate profit in business before depreciation, impairment and financial items.
EBITDA margin refers to EBITDA as a percentage of net sales and is used to proportion EBITDA in relation to net sales and improve comparability of EBITDA over reporting periods.
TALENOM PLC Board of Directors
Otto-Pekka Huhtala CEO, Talenom Plc +358 40 703 8554 [email protected]
Have a question? We'll get back to you promptly.